Proxygen
PrivateLast Round
Strategic
Apr 5, 2023
Total Funding Raised
$250,000
Company Overview
Proxygen is a biotechnology company developing a new class of therapeutics based on induced proximity to address high-value targets in oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proxygen Comparables
Compare Proxygen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neomorph | 89% | |
| Degron Therapeutics | 88% | |
| Plexium | 88% | |
Proxygen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 5, 2023 | ||||
| Strategic | Jun 2, 2022 | ||||
| Strategic | Dec 7, 2020 | ||||
| Grant | Jul 31, 2020 |
Key People
Founding team and executive leadership
Proxygen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Grant, Strategic |
| Wlanholding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 49% MoM.
- Aug 8, 2023
Grew 30% QoQ, from 23 to 30 employees.
Proxygen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Proxygen's valuation, stock price, and market status.